BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6274064)

  • 1. Immunological studies of tissue proteinases.
    Poole AR
    Subcell Biochem; 1981; 8():311-56. PubMed ID: 6274064
    [No Abstract]   [Full Text] [Related]  

  • 2. 12-o-Tetradecanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases. High levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G.
    Welgus HG; Connolly NL; Senior RM
    J Clin Invest; 1986 May; 77(5):1675-81. PubMed ID: 3009552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight protease inhibitor of the respiratory tract.
    Kramps JA; Franken C
    Surv Immunol Res; 1982; 1(1):30-6. PubMed ID: 6764834
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel inhibitors of human leukocyte elastase and cathepsin G. Sequence variants of squash seed protease inhibitor with altered protease selectivity.
    McWherter CA; Walkenhorst WF; Campbell EJ; Glover GI
    Biochemistry; 1989 Jul; 28(14):5708-14. PubMed ID: 2775732
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
    Groutas WC; Chong LS; Venkataraman R
    Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteases and pH in chronic wounds.
    Greener B; Hughes AA; Bannister NP; Douglass J
    J Wound Care; 2005 Feb; 14(2):59-61. PubMed ID: 15739652
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoxazoline derivatives as potential inhibitors of the proteolytic enzymes human leukocyte elastase, cathepsin G and proteinase 3: a structure-activity relationship study.
    Groutas WC; Venkataraman R; Chong LS; Yoder JE; Epp JB; Stanga MA; Kim EH
    Bioorg Med Chem; 1995 Feb; 3(2):125-8. PubMed ID: 7796046
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on degradation of cartilage proteoglycan by rheumatoid synovial tissue. Part II: On the property of acid and neutral proteases obtained from rheumatoid synovial tissue (author's transl)].
    Shimizu K; Susuda K; Minami M; Katsura N
    Nihon Seikeigeka Gakkai Zasshi; 1981 Nov; 55(11):1595-605. PubMed ID: 7037996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.
    Gardi C; Cavarra E; Calzoni P; Marcolongo P; de Santi M; Martorana PA; Lungarella G
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):237-45. PubMed ID: 8166647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lysosomal enzymes].
    Aoki Y
    Ryumachi; 1983 Apr; 23(2):125-30. PubMed ID: 6310801
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification and characterization of a serine proteinase inhibitor from human articular cartilage.
    Burkhardt H; Kasten M; Rauls S
    Biochim Biophys Acta; 1987 May; 924(2):312-8. PubMed ID: 3494475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes.
    Briggaman RA; Schechter NM; Fraki J; Lazarus GS
    J Exp Med; 1984 Oct; 160(4):1027-42. PubMed ID: 6384417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
    Janusz MJ; Doherty NS
    J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of plant inhibitors of polymorphonuclear leukocyte elastase, pancreatic elastase, cathepsin G, cathepsin B, Hageman factor fragments, and other serine proteinases.
    Hojima Y; Pisano JJ; Cochrane CG
    Biochem Pharmacol; 1983 Mar; 32(6):985-90. PubMed ID: 6340694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagenolytic enzymes and their naturally occurring inhibitors.
    Sellers A; Murphy G
    Int Rev Connect Tissue Res; 1981; 9():151-90. PubMed ID: 6175596
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G.
    Vartio T; Seppä H; Vaheri A
    J Biol Chem; 1981 Jan; 256(1):471-7. PubMed ID: 6450204
    [No Abstract]   [Full Text] [Related]  

  • 17. Elastase and cathepsin G of human monocytes: heterogeneity and subcellular localization to peroxidase-positive granules.
    Kargi HA; Campbell EJ; Kuhn C
    J Histochem Cytochem; 1990 Aug; 38(8):1179-86. PubMed ID: 2164060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of human granulocyte elastase with peptide aldehydes.
    Cs-Szabó G; Széll E; Elödi P
    FEBS Lett; 1986 Jan; 195(1-2):265-8. PubMed ID: 3510904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of proteinases in rheumatoid synovium. Detection of leukocyte elastase cathepsin G and another serine proteinase.
    Saklatvala J; Barrett AJ
    Biochim Biophys Acta; 1980 Sep; 615(1):167-77. PubMed ID: 6159006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of lysosomal and nonlysosomal proteases of fibrosarcoma induced by methylcholanthrene.
    Gołaszewski Z; Sobolewski K; Gołaszewska J; Pałka J; Ostrowska H
    Rocz Akad Med Bialymst; 1997; 42(1):213-7. PubMed ID: 9581482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.